Target validation and target invalidation are keys to early drug discovery. Polyclone follows a multidisciplinary approach and offers a streamlined process for efficient target validation and drug discovery. We offer customized screening programs to ensure early and late lead candidate drug optimization. We use of a combination of genomics, proteomics and cell-biology based approaches including gene expression analysis, protein inhibition and cellular processes. Our services in this field include cell-based assays for both cell lines and primary cultures, stem cell based assays, molecular biology services, ELISA, flow cytometry, gene expression analysis, proteomics approaches and microarray based services.